CBOA
AERI

Commonwealth Bank of Australia’s Aerie Pharmaceuticals AERI Stock Holding History

Commonwealth Bank of Australia’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,000
Closed -$233K – 1068
2014
Q1 		$233K Buy
11,000
+300
+3% +$6.06K ﹤0.01% 1182
2013
Q4 		$192K Buy
+10,700
New +$139K ﹤0.01% 1179

Other funds holding AERI

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Commonwealth Bank of Australia's AERI Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of Aerie Pharmaceuticals (AERI) in Q2 2014, closing a stake of 11,000 shares — an estimated $233K sold.

Commonwealth Bank of Australia first reported a position in AERI in Q4 2013 and held it in 2 quarters. The position peaked at $233K in Q1 2014. 60 funds tracked by Wall St. Rank hold AERI as of Q2 2014.

  • Commonwealth Bank of Australia reported no remaining Aerie Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 11,000 Aerie Pharmaceuticals shares in Q2 2014, an estimated $233K.
  • Commonwealth Bank of Australia first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 2 quarters.
  • Commonwealth Bank of Australia's Aerie Pharmaceuticals position peaked at $233K in Q1 2014.
  • 60 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.